Top Markets
#1 Pleasing Gold Pleasing Gold +1,548.36%
#2 PulseChain PulseChain +58.48%
#3 Merlin's Seal BTC Merlin's Seal BTC +32.56%
#4 Ontology Gas Ontology Gas +32.42%
#5 BOOK OF MEME BOOK OF MEME +30.49%
#6 Pump.fun Pump.fun +24.97%
#7 Unit Pump Unit Pump +24.97%
#8 Nockchain Nockchain +21.96%
#9 RSK Infrastructure Framework RSK Infrastructure Framework +21.19%
#10 Neiro Neiro +19.16%
Coin of the day
Pleasing Gold Pleasing Gold
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
PharmAust Limited PharmAust Limited

PharmAust Limited

PAA
Kedudukan dalam Saham #26700
Operating internationally, including in Switzerland, Australia, Sweden, and the... Operating internationally, including in Switzerland, Australia, Sweden, and the United States, PharmAust Limited specializes in developing targeted cancer treatments for both human and animal applications. The company also cultivates intellectual property in drug discovery, addressing a range of cancers and neurological conditions. Its primary therapeutic candidate is Monepantel (MPL), a small molecule compound currently undergoing Phase II clinical trials for cancer treatment. Beyond its drug development pipeline, PharmAust provides synthetic and medicinal chemistry products and expert services to the global drug discovery and pharmaceutical sectors. The firm also holds a research agreement with the Walter and Eliza Hall Institute, investigating in vitro the effects of MPL on human T-lymphotrophic virus-1 (HTLV-1) infections. Established in 2000, PharmAust Limited is headquartered in Bentley, Australia.
Harga Saham
$0.12164306
Disegerakkan terakhir: 2024-11-11
Modal Pasaran
$38.53M
Perubahan (1 hari)
-4.14%
Perubahan (1 tahun)
0.00%
Negara
AU
Perdagangan PharmAust Limited (PAA)

Kategori

Healthcare
EPS untuk PharmAust Limited (PAA)
EPS setakat June 2024 TTM: $-0.01
Menurut laporan kewangan terkini dan harga saham PharmAust Limited, EPS semasa syarikat (TTM) adalah $-0.01. Pada akhir tahun 2023, syarikat mempunyai EPS sebanyak $-0.01 penurunan berbanding EPS tahun 2022 iaitu $0.00.
Sejarah EPS untuk PharmAust Limited dari 2001 hingga 2026
EPS pada akhir setiap tahun
Tahun EPS Ubah
2026 (TTM) $-0.01 -41.50%
2024 $-0.02 26.36%
2023 $-0.01 248.65%
2022 0.00 19.35%
2021 0.00 -3.13%
2020 0.00 -36.00%
2019 $-0.01 -60.63%
2018 $-0.01 53.01%
2017 $-0.01 -73.82%
2016 $-0.03 61.73%
2015 $-0.02 4.81%
2014 $-0.02 23.03%
2013 $-0.02 -90.70%
2012 $-0.16 -57.64%
2011 $-0.39 1,413.73%
2010 $-0.03 142.86%
2009 $-0.01 -97.72%
2008 $-0.46 -48.36%
2007 $-0.89 96.82%
2006 $-0.45 -40.46%
2005 $-0.76 -18.86%
2004 $-0.94 -11.50%
2003 $-1.06 -45.34%
2002 $-1.94 47.75%
2001 $-1.31 0.00%
EPS untuk syarikat atau pesaing yang serupa
Syarikat EPS Perbezaan EPS Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -148,134.19%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -237,194.02%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $2.98 -25,570.09%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $-7.98 68,105.13%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH